Angiotensin II is a key element in regulating the volume of extracellular l
iquid. It acts indirectly through aldosterone secretion by adrenals and dir
ectly on the renal tubule too. it regulates luminal Na+/H+ antiporters (NHE
3 and possibly NHE2) after binding to membrane AT(1) receptors located both
on the basolateral and on the apical side of the cells. The main site of A
ng II action is proximal tubule, mainly the S1 segment which has a high lev
el of AT(1) receptors. Circulating Ang ii concentrations (10(-12) to 10(-10
) M), increased NaCl, water and NaHCO3 reabsorption via NHE3 in the proxima
l tubule. There is also a synthesis of Ang II within the cells of proximal
tubule, which is secreted within the lumen where the physiological concentr
ation is stable 10(-8) M, i.e. 100 to 1000 times higher than the circulatin
g concentration. Luminal ANG II originating from kidney has a physiological
autocrine function on NaCl, water and probably NaHCO3 reabsorption, since
inhibiting Ang II synthesis, by conversion enzyme inhibition, or effect, by
AT(1) receptor antagonists, induces a reduction of proximal tubule reabsor
ption. The stimulatory effects of circulating and intrarenal Ang it seem to
be explained by protein kinase C stimulation and possibly by a reduction o
f cAMP production or by a stimulation of a non-receptor tyrosine kinase.
When pharmacological doses of Ang II (> 10(-8) M) are applied in the peritu
bular or the luminal medium of isolated microperfused proximal tubule in vi
tro, a paradoxical inhibition of NHE3 was observed. These effects appear to
involve arachidonic acid metabolites through the cytochrome P450 pathway a
nd possibly a rise in cytosolic free Ca++. The physiological significance o
f these supraphysiological effects are unknown.